Active Ingredient (In Each Lozenge)
Nicotine polacrilex 4 mg
Nicotine polacrilex 2 mg
The following Structured Product Label (SPL) was submitted to the FDA by A-s Medication Solutions for the product Nicotine (NDC 50090-8151). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each lozenge), purpose, use, otc - pregnancy or breast feeding, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, stop use and ask a doctor if, directions (4 mg lozenge), and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Nicotine polacrilex 4 mg
Nicotine polacrilex 2 mg
Stop smoking aid
If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.
| Weeks 1 to 6 | Weeks 7 to 9 | Weeks 10 to 12 |
| 1 lozenge every 1 to 2 hours | 1 lozenge every 2 to 4 hours | 1 lozenge every 4 to 8 hours |
| Weeks 1 to 6 | Weeks 7 to 9 | Weeks 10 to 12 |
| 1 lozenge every 1 to 2 hours | 1 lozenge every 2 to 4 hours | 1 lozenge every 4 to 8 hours |
Inactive ingredients aspartame, calcium polycarbophil, flavor, maltodextrin, mannitol, sodium alginate, sodium bicarbonate, sodium stearyl fumarate, talc, xanthan gum
Call 1-844-474-7464
Distributed by:
Rising Pharma Holdings, Inc.
East Brunswick, NJ 08816
Issued: 04/2023
* Please review the disclaimer below.